Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Leukemias”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00000589
What this trial is testing

Trial to Reduce Alloimmunization to Platelets (TRAP)

Who this might be right for
Blood PlateletsHematologic DiseasesImmunization+2 more
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Study completedNCT01392989
What this trial is testing

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Who this might be right for
Neural Tube DefectsAnemiaLeukemia, Myeloid+3 more
Everett Meyer 44
Early research (Phase 1)Study completedNCT00383474
What this trial is testing

Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia+18 more
National Cancer Institute (NCI) 35
Not applicableStudy completedNCT03262974
What this trial is testing

Effect of Pharmacogenetics on Imatinib Plasma Level and Response

Who this might be right for
Chronic Myeloid Leukemia
Assiut University 60
Not applicableNot Yet RecruitingNCT06865443
What this trial is testing

Evaluation of CD47, "Do Not Eat Me" Signal Expression in Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia (CML)
Assiut University 50
Early research (Phase 1)Study completedNCT00255710
What this trial is testing

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Not applicableStudy completedNCT00919425
What this trial is testing

S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
SWOG Cancer Research Network 1,294
Not applicableNot Yet RecruitingNCT07518940
What this trial is testing

ENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid Leukemia

Who this might be right for
Myeloproliferative DiseasePolycythemia VeraThrombocythemia Essential+2 more
Carmen Fava 25
Early research (Phase 1)Study completedNCT00131989
What this trial is testing

Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+14 more
National Cancer Institute (NCI) 48
Large-scale testing (Phase 3)Study completedNCT00909168
What this trial is testing

Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
University Hospital, Udine, Italy 130
Early research (Phase 1)Study completedNCT00479232
What this trial is testing

Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)

Who this might be right for
Leukemia, Myelocytic, Acute Myelodysplastic SyndromesMyelodysplastic Syndromes
Merck Sharp & Dohme LLC 71
Testing effectiveness (Phase 2)Study completedNCT00003116
What this trial is testing

High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Case Comprehensive Cancer Center 66
Testing effectiveness (Phase 2)Study completedNCT00118352
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+61 more
Fred Hutchinson Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT02416908
What this trial is testing

Study of CLAG + Selinexor in Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Washington University School of Medicine 40
Early research (Phase 1)Ended earlyNCT00514189
What this trial is testing

Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT00780598
What this trial is testing

Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML

Who this might be right for
Acute Myeloid LeukemiaAML
Chroma Therapeutics 76
Testing effectiveness (Phase 2)Study completedNCT01611116
What this trial is testing

Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia

Who this might be right for
Acute Myeloblastic Leukemia
Goethe University 33
Testing effectiveness (Phase 2)Study completedNCT01826214
What this trial is testing

Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia

Who this might be right for
Acute Leukemias
Novartis Pharmaceuticals 70
Not applicableEnded earlyNCT07004816
What this trial is testing

The Mutation Profile and Prognosis in AML With IDH1/2 Mutation

Who this might be right for
AML
Institute of Hematology & Blood Diseases Hospital, China 1,015
Early research (Phase 1)Ended earlyNCT00004058
What this trial is testing

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Medicine and Dentistry of New Jersey
Next Page